See What HealthDay Can Do For You
Contact Us

October 2006 Briefing - Diabetes & Endocrinology

Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for October 2006. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

Rimonabant Can Reduce Weight in Type 2 Diabetics

MONDAY, Oct. 30 (HealthDay News) -- A daily dose of 20 milligrams of rimonabant combined with an exercise and diet regimen can help diabetes patients lose weight and improve their hemoglobin A1c (HbA1c), according to study findings published online Oct. 27 in The Lancet.

Abstract
Full Text (subscription or payment may be required)
Editorial

FDA Issues Updated Alert on Fake Glucose Strips

THURSDAY, Oct. 26 (HealthDay News) -- The U.S. Food and Drug Administration has updated its earlier nationwide alert on fake blood glucose test strips, adding two additional lot numbers of counterfeit products that have been distributed to pharmacies and stores across the country.

More Information

Racial Disparities Seen in Medicare Managed Care Plans

TUESDAY, Oct. 24 (HealthDay News) -- Quality of care is worse for black Medicare managed-care enrollees than their white counterparts, largely due to different outcomes in the same plan, not plan selection, according to a new analysis in the Oct. 25 issue of the Journal of the American Medical Association.

Abstract
Full Text (subscription or payment may be required)

Anxiety Disorders Associated with Physical Conditions

MONDAY, Oct. 23 (HealthDay News) -- Anxiety disorders are linked with many serious physical conditions, a co-morbidity that increases the risk of disability and a poor quality of life, according to the results of a study published in the Oct. 23 issue of the Archives of Internal Medicine.

Abstract
Full Text (subscription or payment may be required)

U.S., Canada, Mexico Target Fake Diabetes Cures on Web

MONDAY, Oct. 23 (HealthDay News) -- The U.S. Food and Drug Administration has joined forces with the Federal Trade Commission and government agencies from Canada and Mexico to halt Web sales of phony diabetes treatments and cures. The FDA also launched a new campaign in English, Spanish and French aimed at educating the public about fraudulent diabetes cures.

More Information
More Information

Sleep Deprivation Contributes to Obesity in Children

FRIDAY, Oct. 20 (HealthDay News) -- Children who do not sleep enough at night may be at risk for obesity, and banning cell phones, computers and televisions from children's bedrooms could help combat the problem, according to an article published online Oct. 20 in the Archives of Diseases in Childhood.

Abstract
Full Text (subscription or payment may be required)

Increased Mortality Seen in Older Diabetics

FRIDAY, Oct. 20 (HealthDay News) -- Compared to older non-diabetic adults, older diabetics have a significantly increased risk of death, including a twofold higher risk of death from cardiovascular disease, even when their diabetes is treated, according to a study published in the October issue of the open-access journal PLoS-Medicine.

Full Text
Editorial

High-Dose Fluticasone Impairs Adrenal Function in Children

FRIDAY, Oct. 20 (HealthDay News) -- Children prescribed more than the maximum recommended daily dose of inhaled fluticasone proprionate are more likely to experience adrenal insufficiency, according to a report in the October issue of the Archives of Disease in Childhood.

Abstract
Full Text (subscription or payment may be required)
Editorial

Obesity Boosts Complications of Sleep Apnea Surgery

THURSDAY, Oct. 19 (HealthDay News) -- Patients undergoing surgery to relieve sleep apnea are at higher risk of serious complications if they have other medical conditions, are undergoing concurrent non-nasal procedures, have more severe sleep apnea, or have a high body mass index, according to a study in the October issue of Archives of Otolaryngology--Head and Neck Surgery.

Abstract
Full Text (subscription or payment may be required)

Anti-Aging Hormone Supplements Not Effective

WEDNESDAY, Oct. 18 (HealthDay News) -- Neither dehydroepiandrosterone (DHEA) nor low-dose testosterone replacement therapy are effective as anti-aging supplements for elderly women and men, according to a two-year, double-blind, placebo-controlled study published in the Oct. 19 issue of the New England Journal of Medicine.

Abstract
Full Text (subscription or payment may be required)
Editorial

Hypothyroidism May Improve Survival in Head, Neck Cancer

WEDNESDAY, Oct. 18 (HealthDay News) -- Hypothyroidism seems to be associated with better survival in patients with advanced-stage head and neck cancers, according to a report in the October issue of the Archives of Otolaryngology - Head & Neck Surgery.

Abstract
Full Text

Adverse Drug Events Lead to Emergency Department Visits

TUESDAY, Oct. 17 (HealthDay News) -- Adverse drug events, or ADEs, may account for more than 700,000 emergency department visits in the United States each year, and the elderly are at higher risk of visits and hospitalizations than younger patients, researchers report in the Oct. 18 issue of the Journal of the American Medical Association.

Abstract
Full Text (subscription or payment may be required)

New Diabetes Drug Januvia Wins FDA Approval

TUESDAY, Oct. 17 (HealthDay News) -- The U.S. Food and Drug Administration has approved the first in a new line of drugs that increase the body's glucose-lowering potential. The drug, called Januvia (sitagliptin phosphate), is made in tablet-form by Merck & Co., and is to be used for the treatment of type 2 diabetes, along with exercise and diet.

More Information

Bone Development Depends on Insulin-Like Growth Factor-I

TUESDAY, Oct. 17 (HealthDay News) -- Insulin-like growth factor-I (IGF-I) is essential for embryonic bone development, researchers report in the October issue of Endocrinology.

Abstract
Full Text

FDA Issues Alert for Fake Blood Glucose Test Strips

MONDAY, Oct. 16 (HealthDay News) -- The U.S. Food and Drug Administration has issued a nationwide alert for counterfeit blood glucose test strips sold for use with LifeScan, Inc., OneTouch Brand Blood Glucose Monitors. The strips -- OneTouch Basic/Profile (lot #272894A, 2619932 or 2606340) and OneTouch Ultra (lot #2691191) -- could show false blood glucose levels, causing patients to take too little or too much insulin.

More Information -- OneTouch
More Information -- FDA

Proteolysis Elevated in HIV+ with Insulin Resistance

FRIDAY, Oct. 13 (HealthDay News) -- Fasting proteolysis is significantly higher in patients with HIV infection who have impaired glucose tolerance (IGT) than in HIV-negative patients and HIV-infected patients without IGT, according to a report published in the October issue of Diabetes. The increase in proteolysis may exacerbate hyperglycemia in HIV-infected patients.

Abstract
Full Text (subscription or payment may be required)

Gene Variants Associated with Common Obesity

FRIDAY, Oct. 13 (HealthDay News) -- Bardet-Biedl syndrome gene variants are associated with the risk of common obesity in children and adults, according to the results of a study published in the October issue of Diabetes.

Abstract
Full Text (subscription or payment may be required)

Race, Sex, Age Impact Level-I Trauma Center Transfers

THURSDAY, Oct. 12 (HealthDay News) -- Even after controlling for injury severity, non-clinical factors such as race, gender, age and insurance status significantly impact a patient's risk for hospital transfer to level-I trauma centers, researchers report in the October issue of the Journal of Bone and Joint Surgery.

Abstract
Full Text (subscription or payment may be required)

Gene Polymorphism Linked to Type 2 Diabetes Complications

THURSDAY, Oct. 12 (HealthDay News) -- In patients with type 2 diabetes, a polymorphism in the alpha-adducin 1 (ADD1) gene is associated with an increased risk of macrovascular complications and death, according to a brief report published in the October issue of Diabetes.

Abstract
Full Text

Serious Complications for Undiagnosed Diabetes Cases

THURSDAY, Oct. 12 (HealthDay News) -- Nearly one-third of diabetes cases in the United States remain undiagnosed, and many of these already have diabetes-associated complications, including nephropathy, according to a report in the September/October issue of the Annals of Family Medicine.

Abstract
Full Text

Soy Exposure Alters Mammary Glands in Neonatal Mice

WEDNESDAY, Oct. 11 (HealthDay News) -- Neonatal mice exposed to the phytoestrogen genistein, which is found in soy products, have altered mammary gland morphogenesis and hormone receptor levels, and the effect is dose-dependent and persists past puberty, according to research published in the October issue of Endocrinology.

Abstract
Full Text (subscription or payment may be required)

Food, Drug Cravings Activate Similar Parts of Brain

FRIDAY, Oct. 6 (HealthDay News) -- In obese patients, the sensation of satiety activates the hippocampus and other regions of the brain that have been previously shown to be involved in drug craving, according to a report published online Oct. 5 in the Proceedings of the National Academy of Sciences Early Edition.

Abstract
Full Text

Diabetes Risk Associated with Schizophrenia Drugs

THURSDAY, Oct. 5 (HealthDay News) -- Among schizophrenics taking medication for their condition, about one-third of new-onset diabetes cases may be attributable to their anti-psychotic medication, according to a study in the Oct. 1 issue of the American Journal of Epidemiology.

Abstract
Full Text (subscription or payment may be required)

Anti-Obesity Drug Deemed a Clinical Failure

TUESDAY, Oct. 3 (HealthDay News) -- The investigational anti-obesity drug MK-0557, a selective neuropeptide Y5 receptor antagonist, does not lead to a clinically meaningful weight loss in obese patients, according to a study published in the October issue of Cell Metabolism.

Abstract
Full Text (subscription or payment may be required)
Editorial

Weight Loss Is Best Protection for Those at Diabetes Risk

TUESDAY, Oct. 3 (HealthDay News) -- The best safeguard against diabetes for those at diabetes risk is to lose weight, with a 16 percent drop in risk for each kilogram lost, according to a report published in the September issue of Diabetes Care.

Abstract
Full Text

Physician's Briefing

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.